Live Breaking News & Updates on Engineering Analgesic Peptides

PreveCeutical Medical Inc.: PreveCeutical Provides Corporate Update
Vancouver, British Columbia (Newsfile Corp. - May 31, 2021) -
PreveCeutical Medical Inc. (the Company or PreveCeutical ) (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is pleased to provide the following update.
The Company s highest priority is to create shareholder value through the development and commercialization of products and delivery technology.
The Company has partnered with UniQuest Pty Limited and the University of Queensland through its Australian subsidiary, PreveCeutical (Australia) Pty Ltd, to conduct research and development. The Company is very pleased with the positive outcome from the successful completion of the following programs:
Stabilization of Blue Scorpion Venom was completed in October 2019. ....

United States , United Kingdom , British Columbia , Rajit Shetty , Aditya Bahl , Linnea Olofsson , Stephen Van Deventer , Australian Patent Office , Gel Formulation Development , University Of Queensland , Disulfide Linker Technology In Engineering Analgesic Peptides , Preveceutical Australia Pty Ltd , British Columbia Newsfile Corp , Uniquest Pty , Company Or Preveceutical , Preveceutical Medical Inc , Neither The Canadian Securities Exchange , Canadian Securities Exchange , Regulation Services Provider , Ceutical Medical , Uniquest Pty Limited , Pty Ltd , Blue Scorpion Venom , Nasal Delivery , Linker Technology , Engineering Analgesic Peptides ,